Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava-Reference-Cited by-同舟云学术

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava

Published:2017-07-27 Issue:1 Volume:23 Page:134-141
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Tanaka Yoshimi,Hatakeyama Shingo^ORCID,Hosogoe Shogo,Tanaka Toshikazu,Hamano Itsuto,Kusaka Ayumu,Iwamura Hiromich,Fujita Naoki,Yamamoto Hayato,Tobisawa Yuki,Yoneyama Tohru,Yoneyama Takahiro,Hashimoto Yasuhiro,Koie Takuya,Ohyama Chikara

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/article/10.1007/s10147-017-1169-z/fulltext.html

Reference21 articles.

1. Karam JA, Devine CE, Urbauer DL et al (2014) Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. Eur Urol 66(5):874–880. doi: 10.1016/j.eururo.2014.01.035

2. Thomas AA, Rini BI, Lane BR et al (2009) Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. J Urol 181(2):518–523. doi: 10.1016/j.juro.2008.10.001 (discussion 523)

3. Cowey CL, Amin C, Pruthi RS et al (2010) Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. J Clin Oncol 28(9):1502–1507. doi: 10.1200/jco.2009.24.7759